Consumer Health Services

Integrated Consumer Engagement and Support Solutions

Complete, compliant solutions for today's evolving Consumer Health landscape.

ProPhama's Consumer Health Services

Consumer Health Services provide compliant, end-to-end support across consumer engagement, safety monitoring, and quality processes. Expertise spans diverse product portfolios and global markets, ensuring accurate information delivery, consistent consumer experiences, and alignment with regulatory requirements.

Woman shopping at store with smartphone
Braining storming at a business meeting

Our Approach

An Integrated Consumer Health Model

An integrated Consumer Health model supports engagement across multiple touchpoints, including the management of consumer inquiries, proactive identification of Adverse Events and Product Quality Complaints, and timely documentation and reporting in accordance with regulatory requirements. Engagement, safety monitoring, and quality processes are connected to support a consistent, compliant, and consumer-centric experience while safeguarding critical product and patient information.

Structured support solutions strengthen compliance, operational consistency, and risk management across the Consumer Health Service line. Established procedures and controlled processes support data integrity, audit readiness, and regulatory expectations, while enabling accurate identification, documentation, and reporting of safety and quality information within required timelines.

Consumer Health Capabilities

Consumer Health & Information Delivery
Patient support programs icon

Customized Consumer Health Solutions

Tailored service programs designed to your specific needs across diverse product portfolios. These solutions are strategically configured to meet therapeutic area...

Read More

Customized Consumer Health Solutions

Tailored service programs designed to your specific needs across diverse product portfolios. These solutions are strategically configured to meet therapeutic area requirements and product classifications, such as Over-the-Counter (OTC), Nutritional, Cosmeceutical, and Prescription products. Our dedicated call center operations and Consumer Health teams provide expert support by delivering on-label information sourced from approved FAQs and regulatory resources, ensuring consistent and compliant support for both healthcare professionals and consumer inquiries.

Read Less
Decentralized Clinical Trials icon

Over-the-Counter and Retail Product Services

ProPharma direct-to-consumer Consumer Health Services for OTC products has become your primary connection point with end users, delivering the exceptional...

Read More

Over-the-Counter and Retail Product Services

ProPharma direct-to-consumer Consumer Health Services for OTC products has become your primary connection point with end users, delivering the exceptional service quality that drives brand loyalty and repeat purchases.

Read Less
Entrepreneurial

Community Management Capabilities

Modern Consumer Health Services leverage digital platforms to monitor sponsored content and influence partnerships across a range of digital and social media...

Read More

Community Management Capabilities

Modern Consumer Health Services leverage digital platforms to monitor sponsored content and influence partnerships across a range of digital and social media environments.

  • Standardized medical information responses delivered in alignment with approved product labeling and FAQs.
  • Social media and ecommerce monitoring
  • Trend Analysis Reports
Read Less
Pharmacovigilance

Safety & Quality Oversight

Highly Qualified Experts

Consumer Health Services serve as the critical first point of contact for Adverse Events and Product Quality Complaints reporting. Our trained specialists conduct thorough assessments to capture complete Adverse Event and Product Quality Complaint information. Consumer Health Services manage end-to-end quality complaint processes, from documentation through quality assurance coordination and consumer updates.

Global contact center support icon

Consumer Access & Support Programs

Product Reimbursement, Replacement Programs & Financial Assistance

Consumer Health Services provide specialized reimbursement and replacement support.

  • Facilitation of physical and digital coupon distribution.
  • Financial assistance and Co-Pay programs.
  • Sample retrieval services manage specialized logistics including prepaid shipping, proper packaging, and chain of custody
Around the world icon

Global Delivery & Operational Excellence

Multilingual Services

Support available in 35+ languages to serve diverse consumer populations globally.

Contact a Consumer Health Expert

We are committed to supporting consumer safety and experience through our competitive Consumer Health Services. Whether you require robust monitoring of digital and social channels or a full-service approach including engagement and response management, our team of experts is equipped to ensure timely, accurate, and compliant handling of all consumer interactions.

News & Insights

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

July 14, 2026

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

Learn what the first EU Joint Clinical Assessments reveal about evidence planning, PICO strategy, and HTA readiness for successful market access.

Turning Regulatory Complexity into Predictable Study Start-Up Execution

July 13, 2026

Turning Regulatory Complexity into Predictable Study Start-Up Execution

Explore how organizations can navigate regulatory complexity in clinical trials to achieve predictable study start-up timelines and operational excellence.

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

July 6, 2026

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Discover how regulatory readiness has evolved into a strategic advantage for clinical study start-ups in Europe, impacting timelines and operational efficiency.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

June 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

News & Insights

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

July 14, 2026

First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA

Learn what the first EU Joint Clinical Assessments reveal about evidence planning, PICO strategy, and HTA readiness for successful market access.

Turning Regulatory Complexity into Predictable Study Start-Up Execution

July 13, 2026

Turning Regulatory Complexity into Predictable Study Start-Up Execution

Explore how organizations can navigate regulatory complexity in clinical trials to achieve predictable study start-up timelines and operational excellence.

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

July 6, 2026

Regulatory Readiness as a Strategic Advantage in European Study Start-Up

Discover how regulatory readiness has evolved into a strategic advantage for clinical study start-ups in Europe, impacting timelines and operational efficiency.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

June 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Previous Resource Arrow Next Resource Arrow
Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Previous Webinar Arrow Next Webinar Arrow